Citation: Ca. Kruse et D. Rubinstein, Cytotoxic T-lymphocytes reactive to patient major histocompatibility complex proteins for therapy of brain tumors, BRAIN TUMOR IMMUNOTHERAPY, 2001, pp. 149-170
Authors:
Kruse, CA
Lamb, C
Hogan, S
Smiley, WR
Kleinschmidt-DeMasters, BK
Burrows, FJ
Citation: Ca. Kruse et al., Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms, CANC GENE T, 7(1), 2000, pp. 118-127
Authors:
Kruse, CA
Visonneau, S
Kleinschmidt-DeMasters, BK
Gup, CJ
Gomez, GG
Paul, DB
Santoli, D
Citation: Ca. Kruse et al., The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: Implications for local adoptive immunotherapy, CANCER RES, 60(20), 2000, pp. 5731-5739